Laboratory automation on the agenda but expense may limit investment to partial solutions
This article was originally published in Clinica
The early promise of total laboratory automation (TLA) has been hampered by its high initial cost. At last week's American Association for Clinical Chemistry (AACC) meeting in New Orleans, Neena Brizmohun looked at the new generation of modular automated systems offering more flexible and affordable options.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.